欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saccharomyces cerevisiae Leu/Val/Ile amino-acid permease (BAP2), partial CSB-YP327776SVG
CSB-EP327776SVG
CSB-BP327776SVG
CSB-MP327776SVG
CSB-EP327776SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae General amino acid permease AGP2 (AGP2), partial CSB-YP327777SVG
CSB-EP327777SVG
CSB-BP327777SVG
CSB-MP327777SVG
CSB-EP327777SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Putative urea carboxylase (lamA), partial CSB-YP327778EKF
CSB-EP327778EKF
CSB-BP327778EKF
CSB-MP327778EKF
CSB-EP327778EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Uncharacterized membrane protein PA4757 (PA4757), partial CSB-YP327779EZX1
CSB-EP327779EZX1
CSB-BP327779EZX1
CSB-MP327779EZX1
CSB-EP327779EZX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Starvation-sensing protein rspA (rspA) CSB-YP327780ENV
CSB-EP327780ENV
CSB-BP327780ENV
CSB-MP327780ENV
CSB-EP327780ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Serine/threonine-protein kinase MEC1 (MEC1), partial CSB-YP327781SVG
CSB-EP327781SVG
CSB-BP327781SVG
CSB-MP327781SVG
CSB-EP327781SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Undecaprenyl pyrophosphate synthase 1 (uppS1) CSB-YP327782DWY
CSB-EP327782DWY
CSB-BP327782DWY
CSB-MP327782DWY
CSB-EP327782DWY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae 37S ribosomal protein S9, mitochondrial (MRPS9) CSB-YP327783SVG
CSB-EP327783SVG
CSB-BP327783SVG
CSB-MP327783SVG
CSB-EP327783SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Fluconazole resistance protein 1 (FLR1), partial CSB-YP327784SVG
CSB-EP327784SVG
CSB-BP327784SVG
CSB-MP327784SVG
CSB-EP327784SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Peroxisomal-coenzyme A synthetase (PCS60), partial CSB-YP327785SVG
CSB-EP327785SVG
CSB-BP327785SVG
CSB-MP327785SVG
CSB-EP327785SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae ISWI chromatin-remodeling complex ATPase ISW1 (ISW1), partial CSB-YP327786SVG
CSB-EP327786SVG
CSB-BP327786SVG
CSB-MP327786SVG
CSB-EP327786SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Inactive deaminase YBR284W (YBR284W), partial CSB-YP327787SVG1
CSB-EP327787SVG1
CSB-BP327787SVG1
CSB-MP327787SVG1
CSB-EP327787SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae AP-3 complex subunit mu (APM3) CSB-YP327788SVG
CSB-EP327788SVG
CSB-BP327788SVG
CSB-MP327788SVG
CSB-EP327788SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Maltose fermentation regulatory protein MAL33 (MAL33) CSB-YP327789SVG
CSB-EP327789SVG
CSB-BP327789SVG
CSB-MP327789SVG
CSB-EP327789SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Lethal (2) giant larvae protein homolog SRO77, partial CSB-YP327790SVG
CSB-EP327790SVG
CSB-BP327790SVG
CSB-MP327790SVG
CSB-EP327790SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YBL094C (YBL094C), partial CSB-YP327791SVG1
CSB-EP327791SVG1
CSB-BP327791SVG1
CSB-MP327791SVG1
CSB-EP327791SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YBL086C (YBL086C) CSB-YP327792SVG
CSB-EP327792SVG
CSB-BP327792SVG
CSB-MP327792SVG
CSB-EP327792SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Autophagy-related protein 8 (ATG8) CSB-YP327793SVG
CSB-BP327793SVG
CSB-MP327793SVG
CSB-EP327793SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YBL053W (YBL053W), partial CSB-YP327794SVG1
CSB-EP327794SVG1
CSB-BP327794SVG1
CSB-MP327794SVG1
CSB-EP327794SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uridine permease (FUI1), partial CSB-YP327795SVG
CSB-EP327795SVG
CSB-BP327795SVG
CSB-MP327795SVG
CSB-EP327795SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×